The blood test can predict the risk of death from heart attack: research

The research findings are an exciting new development, building on more than 10 years of collaborative research on stress hormones. Oxford University
Dawn Medical Editor
LONDON: British research has found that a new cheap and simple blood test can help identify people who are most at risk of dying from heart failure, Professor Neill of Cardiovascular Medicine and Consultant Cardiologist at the University of Oxford. Herring said: ‘The results of this study are an exciting new development, building on more than 10 years of collaborative research on stress hormones. We hope that our research will ultimately benefit the growing number of patients who suffer from heart disease every day. “We will then investigate whether high levels of neuropeptide Y can affect whether patients come back within five years before starting blood tests.” Can get life-saving treatments like CDs.’
Heart failure occurs when the heart cannot pump blood around the body as well as it should. It leads to frequent hospital visits and reduced quality of life, and there is currently no cure. More than a million people in the UK suffer from possible heart failure and around two million new people are diagnosed in the UK each year. A three-year study found that patients who had the highest levels of a particular protein with low doses were 50 percent more likely to die from a heart complication than those with low doses.
Testing for this protein, called neuropeptide Y (NPY), can help predict how the risk of heart failure may increase, experts say.
Researchers hope a blood test could be used to help treat heart failure patients within five years, says Professor Brian Williams, chief scientific and medical officer at the British Heart Foundation (BHF). “This new research suggests that a new, cheap, and simple blood test could in the future help us more accurately identify which heart failure patients are at greatest risk of early death.” “Funding life-saving research like this can go a long way and ensure that people with heart failure get the best and most appropriate treatment so they can live well.” The research, published in the European Journal of Heart Failure and funded by the Heart Foundation, was carried out in collaboration with Professor Pradeep Jhand of the University of Glasgow.